Market Value4,948,235,000
Total Holdings58
File Date2022-02-14
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
OYST / Oyster Point Pharma Inc
NET / Cloudflare, Inc.
LXRX / Lexicon Pharmaceuticals, Inc.
SBBP / Strongbridge Biopharma plc
BE / Bloom Energy Corporation
US0846561076 / Berkshire Grey, Inc.
MILE / Metromile Inc
VTGN / Vistagen Therapeutics, Inc.
TRIL / Trillium Therapeutics Inc
SVRA / Savara Inc.
VRNA / Verona Pharma plc - Depositary Receipt (Common Stock)
CVRX / CVRx, Inc.
COUR / Coursera, Inc.
BDTX / Black Diamond Therapeutics, Inc.
CRSP / CRISPR Therapeutics AG
AUPH / Aurinia Pharmaceuticals Inc.
BHG / Bright Health Group, Inc.
HOOD / Robinhood Markets, Inc.
GRTX / Galera Therapeutics, Inc.
EAR / Eargo, Inc.
EYRYY / Erytech Pharma
XENE / Xenon Pharmaceuticals Inc.
LUMO / Lumos Pharma, Inc.
AKUS / Akouos Inc
MEIP / MEI Pharma, Inc.
MTCR / Metacrine Inc
BILL / BILL Holdings, Inc.
VIRX / Viracta Therapeutics, Inc.
ARDX / Ardelyx, Inc.
VECT / VectivBio Holding AG
CSPR / Casper Sleep Inc
STSA / Satsuma Pharmaceuticals Inc
IMRA / Bitwise Funds Trust - Bitwise MARA Option Income Strategy ETF
INZY / Inozyme Pharma, Inc.
GLYC / GlycoMimetics, Inc.
RPHM / Reneo Pharmaceuticals, Inc.
GERN / Geron Corporation
MIMO / Airspan Networks Holdings Inc.
XERS / Xeris Biopharma Holdings, Inc.
GNCA / Genocea Biosciences Inc
ALLK / Allakos Inc.
ANNX / Annexon, Inc.
CTIC / CTI BioPharma Corp
AKTX / Akari Therapeutics, Plc - Depositary Receipt (Common Stock)
PHAS / PhaseBio Pharmaceuticals Inc
OBSV / ObsEva SA.
DMYI.U / dMY Technology Group, Inc. III Units, each consisting of one share of Class A common stock and one-f
TCON / TRACON Pharmaceuticals, Inc.
NN / NextNav Inc.
TRVN / Trevena, Inc.
MRKR / Marker Therapeutics, Inc.
TPST / Tempest Therapeutics, Inc.
UP / Wheels Up Experience Inc.
AFMD / Affimed N.V.
IVA / Inventiva S.A. - Depositary Receipt (Common Stock)
RYTM / Rhythm Pharmaceuticals, Inc.
AVEO / AVEO Pharmaceuticals Inc
CSBR / Champions Oncology, Inc.
GLUE / Monte Rosa Therapeutics, Inc.
SYBX / Synlogic, Inc.
UTRS / Minerva Surgical, Inc.
LQDA / Liquidia Corporation
RGLS / Regulus Therapeutics Inc.
ADXN / Addex Therapeutics Ltd - Depositary Receipt (Common Stock)
BZFD / BuzzFeed, Inc.
TRVI / Trevi Therapeutics, Inc.
NKTX / Nkarta, Inc.
MIRM / Mirum Pharmaceuticals, Inc.
DM / Desktop Metal, Inc.
ADAP / Adaptimmune Therapeutics plc - Depositary Receipt (Common Stock)